Health CanadaGeneral Alert

Risk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon - For Health Professionals

Name: Risk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon - For Health Professionals
Brand: Marketed health products
SKU: CANADA-24248
Availability: Discontinued
Rating: 1.0 (1 reviews)

Published: March 12, 2008Recall ID: 24248Category: generalCountry: Canada

Safety AlertHealth Canada Canada

Canada

Risk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon - For Health Professionals

Recalling Firm: Marketed health products

Product Description & Identification

Risk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon - For Health Professionals

Additional Source Details

Field	Value
N I D	24248
U R L	https://recalls-rappels.canada.ca/en/alert-recall/risk-peripheral-neuropathy-patients-treated-telbivudine-sebivo-and-interferon-health
Title	Risk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon - For Health Professionals
Archived	1
Category	Drugs
Last updated	2008-03-12
Organization	Marketed health products

Check Other Products In Your Household

Free Safety Tools

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Barcode Scanner VIN Vehicle Check Pantry Safety Audit

Overview

Recalling FirmMarketed health products

Recall Hazard Severity

Caution (Class III)

Official Agency Alert

📢 Share Warning

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: Marketed health products - Risk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon - For Health Professionals

Check if your household is affected:
https://therecallfile.com/recalls/risk-of-peripheral-neuropathy-in-patients-treated-with-telbivudine-seb/CANADA-24248

WhatsApp Facebook

Join Alertlist

Get instant email updates whenever critical safety recalls like this are published.

Featured on Product Hunt

Help support our public safety mission and check out our community launch.

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Spread the WordRisk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon - For Health Professionals

Risk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon - For Health Professionals

Risk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon - For Health Professionals

Product Description & Identification

Additional Source Details

Check Other Products In Your Household

Overview

📢 Share Warning

Join Alertlist

Featured on Product Hunt

Support The Recall File

Install The Recall File App

Notification

Risk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon - For Health Professionals

Risk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon - For Health Professionals

Product Description & Identification

Additional Source Details

Check Other Products In Your Household

Overview

📢 Share Warning

Join Alertlist

Featured on Product Hunt

Support The Recall File

Related Recalls

Transport Canada Recall - 2018088 -

Transport Canada Recall - 2018088 -

Transport Canada Recall - 2018288 -

Transport Canada Recall - 2018288 -

Transport Canada Recall - 2018409 -

Transport Canada Recall - 2018409 -

Install The Recall File App

Notification